Granite Investment Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-375,778
| Closed | -$10.9M | – | 256 |
|
|
2025
Q1 | $10.9M | Sell |
375,778
-20,924
| -5% | -$607K | 0.55% | 70 |
|
|
2024
Q4 | $14.7M | Sell |
396,702
-9,016
| -2% | -$335K | 0.64% | 56 |
|
|
2024
Q3 | $19.7M | Buy |
405,718
+8,204
| +2% | +$398K | 0.84% | 31 |
|
|
2024
Q2 | $15.9M | Buy |
397,514
+44,744
| +13% | +$1.79M | 0.66% | 49 |
|
|
2024
Q1 | $15.5M | Sell |
352,770
-12,570
| -3% | -$552K | 0.59% | 64 |
|
|
2023
Q4 | $22.6M | Buy |
365,340
+34,429
| +10% | +$2.13M | 0.88% | 35 |
|
|
2023
Q3 | $15.2M | Sell |
330,911
-202,248
| -38% | -$9.3M | 0.64% | 59 |
|
|
2023
Q2 | $30.6M | Sell |
533,159
-3,662
| -0.7% | -$210K | 1.22% | 12 |
|
|
2023
Q1 | $20.1M | Buy |
+536,821
| New | +$20.1M | 0.84% | 40 |
|